Adjuvant chemotherapy for breast cancer: a cost-utility analysis of FEC-D vs. FEC 100
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-007-9770-x.pdf
Reference38 articles.
1. Trudeau M, Charbonneau F, Gelmon K et al (2005) Selection of adjuvant chemotherapy for treatment of node-positive breast cancer. Lancet Oncol 6(11):886–898
2. Reeder CE, Gordon D (2006) Managing oncology costs. Am J Manag Care 12(S1):S3–S16
3. Smith TJ, Hillner BE (1993) The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in pre-menopausal women. J Clin Oncol 11:771–776
4. Messori A, Becagli P, Trippoli S et al (1996) Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide + methotrexate + fluorouracil in patients with node-positive breast cancer. Eur J Clin Pharmacol 51:111–116
5. Bonneterre J, Bercez C, Bonneterre ME et al (2005) Cost-effectiveness analysis of breast cancer adjuvant treatment: FEC 50 vs. FEC 100 (FASG 05 study). Ann Oncol 16(6):915–9220
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancer;Cost Effectiveness and Resource Allocation;2022-03-01
2. A cost-utility analysis of risk model-guided versus physician’s choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach;Supportive Care in Cancer;2017-03-09
3. Cost–utility analyses of drug therapies in breast cancer: a systematic review;Breast Cancer Research and Treatment;2016-08-30
4. Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer;PharmacoEconomics;2016-04-29
5. Cost-Effectiveness of Chemotherapy for Breast Cancer and Age Effect in Older Women;Value in Health;2015-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3